Successful treatment of placenta accreta spectrum disorder using management strategy of serial uterine artery embolization combined with standard weekly and a 8-day methotrexate/folinic acid regimens at 7 weeks of gestation

Objective: We describe our experience with serial uterine artery embolization (UAE) combined with standard weekly methotrexate and a eight-day methotrexate/folinic acid (MTX/FA) treatment regimen in the management of placenta accreta spectrum (PAS) disorder at 7 weeks of gestation. Case report: A 38...

Full description

Bibliographic Details
Main Authors: Min-Min Chou, Jia-Chun Yuan, Yaw-An Lu, Sheng-Wei Chuang
Format: Article
Language:English
Published: Elsevier 2020-11-01
Series:Taiwanese Journal of Obstetrics & Gynecology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1028455920302382
id doaj-23d53adee4ed4ae49d4cbef2bbf84f35
record_format Article
spelling doaj-23d53adee4ed4ae49d4cbef2bbf84f352020-11-25T04:02:18ZengElsevierTaiwanese Journal of Obstetrics & Gynecology1028-45592020-11-01596952955Successful treatment of placenta accreta spectrum disorder using management strategy of serial uterine artery embolization combined with standard weekly and a 8-day methotrexate/folinic acid regimens at 7 weeks of gestationMin-Min Chou0Jia-Chun Yuan1Yaw-An Lu2Sheng-Wei Chuang3Corresponding author. Center for High Risk Pregnancy and Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, China Medical University Hospital, 2 Yude Road, Taichung 40447, Taiwan. Fax: +886 4 22086970.; Center for High Risk Pregnancy and Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, China Medical University Hospital, Taichung 40447, TaiwanCenter for High Risk Pregnancy and Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, China Medical University Hospital, Taichung 40447, TaiwanCenter for High Risk Pregnancy and Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, China Medical University Hospital, Taichung 40447, TaiwanCenter for High Risk Pregnancy and Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, China Medical University Hospital, Taichung 40447, TaiwanObjective: We describe our experience with serial uterine artery embolization (UAE) combined with standard weekly methotrexate and a eight-day methotrexate/folinic acid (MTX/FA) treatment regimen in the management of placenta accreta spectrum (PAS) disorder at 7 weeks of gestation. Case report: A 38-year-old woman, gravida 2 para 0, with a history of myomectomy, was referred for ultrasound (US) evaluation due to suspected cervico-isthmic pregnancy. Transvaginal US image showed a viable embryo with a disproportionately bigger placenta encircling the fetus and completely covering the internal os of the cervix at 7 weeks of gestation. Color Doppler imaging revealed diffuse intraplacental and periplacental vascularity. Patient chose to terminate the pregnancy but attempted to preserve the uterus for future fertility following counseling. Serial UAE procedures were performed using Gelfoam and metallic microcoils. Two courses of a standard weekly MTX and a eight-day MTX/FA treatment regimen were administered to accelerate placental regression. The beta-hCG gradually decreased to a normal level, and an ultimate resolution of the PAS disorder was observed at 110 days after treatment. Conclusion: Early diagnosis of the PAS disorder could result in better obstetric outcome through earlier intervention using serial UAE combined with standard weekly and a eight day MTX//FA regimen in the first trimester of pregnancy.http://www.sciencedirect.com/science/article/pii/S1028455920302382Methotrexate/folinic acid (MTX/FA) regimenMyomectomyPlacenta accreta spectrum disorderUterine artery embolization
collection DOAJ
language English
format Article
sources DOAJ
author Min-Min Chou
Jia-Chun Yuan
Yaw-An Lu
Sheng-Wei Chuang
spellingShingle Min-Min Chou
Jia-Chun Yuan
Yaw-An Lu
Sheng-Wei Chuang
Successful treatment of placenta accreta spectrum disorder using management strategy of serial uterine artery embolization combined with standard weekly and a 8-day methotrexate/folinic acid regimens at 7 weeks of gestation
Taiwanese Journal of Obstetrics & Gynecology
Methotrexate/folinic acid (MTX/FA) regimen
Myomectomy
Placenta accreta spectrum disorder
Uterine artery embolization
author_facet Min-Min Chou
Jia-Chun Yuan
Yaw-An Lu
Sheng-Wei Chuang
author_sort Min-Min Chou
title Successful treatment of placenta accreta spectrum disorder using management strategy of serial uterine artery embolization combined with standard weekly and a 8-day methotrexate/folinic acid regimens at 7 weeks of gestation
title_short Successful treatment of placenta accreta spectrum disorder using management strategy of serial uterine artery embolization combined with standard weekly and a 8-day methotrexate/folinic acid regimens at 7 weeks of gestation
title_full Successful treatment of placenta accreta spectrum disorder using management strategy of serial uterine artery embolization combined with standard weekly and a 8-day methotrexate/folinic acid regimens at 7 weeks of gestation
title_fullStr Successful treatment of placenta accreta spectrum disorder using management strategy of serial uterine artery embolization combined with standard weekly and a 8-day methotrexate/folinic acid regimens at 7 weeks of gestation
title_full_unstemmed Successful treatment of placenta accreta spectrum disorder using management strategy of serial uterine artery embolization combined with standard weekly and a 8-day methotrexate/folinic acid regimens at 7 weeks of gestation
title_sort successful treatment of placenta accreta spectrum disorder using management strategy of serial uterine artery embolization combined with standard weekly and a 8-day methotrexate/folinic acid regimens at 7 weeks of gestation
publisher Elsevier
series Taiwanese Journal of Obstetrics & Gynecology
issn 1028-4559
publishDate 2020-11-01
description Objective: We describe our experience with serial uterine artery embolization (UAE) combined with standard weekly methotrexate and a eight-day methotrexate/folinic acid (MTX/FA) treatment regimen in the management of placenta accreta spectrum (PAS) disorder at 7 weeks of gestation. Case report: A 38-year-old woman, gravida 2 para 0, with a history of myomectomy, was referred for ultrasound (US) evaluation due to suspected cervico-isthmic pregnancy. Transvaginal US image showed a viable embryo with a disproportionately bigger placenta encircling the fetus and completely covering the internal os of the cervix at 7 weeks of gestation. Color Doppler imaging revealed diffuse intraplacental and periplacental vascularity. Patient chose to terminate the pregnancy but attempted to preserve the uterus for future fertility following counseling. Serial UAE procedures were performed using Gelfoam and metallic microcoils. Two courses of a standard weekly MTX and a eight-day MTX/FA treatment regimen were administered to accelerate placental regression. The beta-hCG gradually decreased to a normal level, and an ultimate resolution of the PAS disorder was observed at 110 days after treatment. Conclusion: Early diagnosis of the PAS disorder could result in better obstetric outcome through earlier intervention using serial UAE combined with standard weekly and a eight day MTX//FA regimen in the first trimester of pregnancy.
topic Methotrexate/folinic acid (MTX/FA) regimen
Myomectomy
Placenta accreta spectrum disorder
Uterine artery embolization
url http://www.sciencedirect.com/science/article/pii/S1028455920302382
work_keys_str_mv AT minminchou successfultreatmentofplacentaaccretaspectrumdisorderusingmanagementstrategyofserialuterinearteryembolizationcombinedwithstandardweeklyanda8daymethotrexatefolinicacidregimensat7weeksofgestation
AT jiachunyuan successfultreatmentofplacentaaccretaspectrumdisorderusingmanagementstrategyofserialuterinearteryembolizationcombinedwithstandardweeklyanda8daymethotrexatefolinicacidregimensat7weeksofgestation
AT yawanlu successfultreatmentofplacentaaccretaspectrumdisorderusingmanagementstrategyofserialuterinearteryembolizationcombinedwithstandardweeklyanda8daymethotrexatefolinicacidregimensat7weeksofgestation
AT shengweichuang successfultreatmentofplacentaaccretaspectrumdisorderusingmanagementstrategyofserialuterinearteryembolizationcombinedwithstandardweeklyanda8daymethotrexatefolinicacidregimensat7weeksofgestation
_version_ 1724443499824152576